Post-Exposure Prophylaxis
"Post-Exposure Prophylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of infection or disease following exposure to a pathogen.
Descriptor ID |
D056990
|
MeSH Number(s) |
N02.421.726.755
|
Concept/Terms |
Post-Exposure Prophylaxis- Post-Exposure Prophylaxis
- Post Exposure Prophylaxis
- Prophylaxis, Post-Exposure
- Post-Exposure Prevention
- Post Exposure Prevention
- Prevention, Post-Exposure
|
Below are MeSH descriptors whose meaning is more general than "Post-Exposure Prophylaxis".
Below are MeSH descriptors whose meaning is more specific than "Post-Exposure Prophylaxis".
This graph shows the total number of publications written about "Post-Exposure Prophylaxis" by people in this website by year, and whether "Post-Exposure Prophylaxis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2014 | 1 | 0 | 1 | 2020 | 1 | 0 | 1 | 2021 | 0 | 1 | 1 | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Post-Exposure Prophylaxis" by people in Profiles.
-
Levin MJ, Ustianowski A, Thomas S, Templeton A, Yuan Y, Seegobin S, Houlihan CF, Menendez-Perez I, Pollett S, Arends RH, Beavon R, Dey K, Garbes P, Kelly EJ, Koh GCKW, Ivanov S, Near KA, Sharbaugh A, Streicher K, Pangalos MN, Esser MT. AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019. Clin Infect Dis. 2023 04 03; 76(7):1247-1256.
-
Epstein RL, Penwill N, Clarke DF, Hamilton S, Horbowicz K, Dorfman D, Moses JM, Cooper ER. "Meds-in-Hand" Intervention to Reduce Critical Process Delays in Pediatric Human Immunodeficiency Virus Post-Exposure Prophylaxis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):196-200.
-
Duchon JM, Levin MJ, Gershon AA. Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program. J Pediatric Infect Dis Soc. 2020 Sep 17; 9(4):449-453.
-
King TH, Shanley CA, Guo Z, Bellgrau D, Rodell T, Furney S, Henao-Tamayo M, Orme IM. GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis. Clin Vaccine Immunol. 2017 Dec; 24(12).
-
Redd AD, Wendel SK, Longosz AF, Fogel JM, Dadabhai S, Kumwenda N, Sun J, Walker MP, Bruno D, Martens C, Eshleman SH, Porcella SF, Quinn TC, Taha TE. Evaluation of postpartum HIV superinfection and mother-to-child transmission. AIDS. 2015 Jul 31; 29(12):1567-73.
-
Asturias EJ. Women scientist and the will to prevent Hib disease. Pediatr Infect Dis J. 2014 Dec; 33(12):1311.
-
Neff CP, Ndolo T, Tandon A, Habu Y, Akkina R. Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model. PLoS One. 2010 Dec 21; 5(12):e15257.
-
Corey KE, Servoss JC, Casson DR, Kim AY, Robbins GK, Franzini J, Twitchell K, Loomis SC, Abraczinskas DR, Terella AM, Dienstag JL, Chung RT. Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers. Infect Control Hosp Epidemiol. 2009 Oct; 30(10):1000-5.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|